8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
An expert overview of the literature, useful as background reading.
2013 / Narrative review
This review examines inflamm-ageing, the chronic low-grade inflammation characteristic of ageing that contributes to health decline and age-related disease. It discusses the roles of senescent cells, metaflammation, gut microbiota, and nutrition in modulating this phenomenon across the human lifespan. The authors emphasize that gut microbiota and nutrition should be utilized to slow inflamm-ageing, potentially promoting healthy ageing and extending lifespan.
Cevenini E, Monti D, Franceschi C Curr Opin Clin Nutr Metab Care, 2013. PMID 23132168
2013 / Narrative review of clinical trials
This review examines clinical trials from the past quarter century addressing the pharmacokinetics, safety, and efficacy of curcumin in humans. Promising effects were noted in patients with diverse pro-inflammatory diseases, such as cancer, cardiovascular disease, arthritis, gastrointestinal conditions, diabetes, and renal diseases. Dose-escalating studies showed curcumin is safe at doses as high as 12 g/day over 3 months. Curcumin modulates numerous human signaling molecules, including pro-inflammatory cytokines, apoptotic proteins, NF-κB, COX-2, STAT3, C-reactive protein, and triglycerides.
Gupta SC, Patchva S, Aggarwal BB AAPS J, 2013. PMID 23143785
2013 / Narrative review
This review examines short chain fatty acids (SCFAs), their receptors, and their relationship with metabolism. In humans, SCFAs are largely generated through the fermentation of carbohydrates and proteins in the colon, allowing energy salvage from otherwise indigestible foods. Recently identified SCFA receptors, FFAR2 and FFAR3, are expressed in the gut epithelium as well as metabolically important tissues including adipose tissue and pancreatic islets.
Layden BT, Angueira AR, Brodsky M, et al. Transl Res, 2013. PMID 23146568
2013 / Narrative review
A review examined the gastrointestinal safety of prescription and over-the-counter (OTC) NSAIDs. Long-term endoscopy studies report ulcer rates from 15% to 35% with NSAIDs, while serious outcomes are exceedingly rare, and mega-trials indicate NSAID-induced gastric bleeding occurs in fewer than 1 in 200 subjects taking them for a year. OTC ibuprofen and diclofenac had symptomatic side effects comparable to placebo, with ibuprofen being remarkably well tolerated. The authors note recent studies suggesting OTC NSAIDs should be taken on a fasting stomach rather than with food.
Bjarnason I Int J Clin Pract Suppl, 2013. PMID 23163547
2013 / Narrative review
This review discusses the CODEX Alimentarius definition of dietary fiber, which includes nondigestible carbohydrate polymers with a degree of polymerization of 3 or more if they demonstrate health benefits. It emphasizes the need for scientific consensus on physiological effects such as laxation, gut health, attenuation of blood lipids, glucose, and insulin, and large bowel fermentation. Research protocols to demonstrate these benefits require evidence-based reviews, well-controlled randomized trials, and animal studies for mechanisms. The definition highlights that combining fiber-rich and fiber-fortified foods can help address the global fiber consumption gap within allowed energy levels.
Jones JM Adv Nutr, 2013. PMID 23319118
2013 / Narrative review
This review synthesized human epidemiological data, clinical trials, and animal studies evaluating the anti-inflammatory roles of dietary fibers. High-fiber diets were linked to lower body weight and reduced inflammatory markers, while fermentable fibers also demonstrated weight-unrelated systemic and local intestinal anti-inflammatory actions. Synbiotics showed no convincing evidence of higher efficacy compared to fiber alone. Adverse effects were not observed at the fiber intakes tested, although individuals with Crohn's disease may exhibit greater sensitivity to inulin.
Kuo SM Adv Nutr, 2013. PMID 23319119
2013 / Narrative review
This review evaluates curcumin, a component of turmeric, as an alternative to expensive injectable TNF-α blockers approved for inflammatory conditions. The authors report that curcumin is orally bioavailable and highly safe in humans, and can block TNF-α production and action across in vitro models, animal models, and human studies. Evidence is discussed regarding curcumin's activity against diseases treated with TNF blockers, along with mechanisms inhibiting TNF production and signalling pathways.
Aggarwal BB, Gupta SC, Sung B Br J Pharmacol, 2013. PMID 23425071
2013 / Review of epidemiological and microbiological studies (2008-2012)
Researchers reviewed recent epidemiological studies and microbiological research published between 2008 and 2012 regarding isoflavone intake, equol-producing flora, and prostate cancer (PCa) risk. Five out of six articles showed a significant association of isoflavones with a decreased risk of PCa, and two of these consistently reported that equol-producers have a significantly reduced risk. Additionally, five human intestinal bacteria capable of converting daidzein into equol were identified within the evaluated timeframe.
Shows an association, not proof of cause and effect.
Sugiyama Y, Masumori N, Fukuta F, et al. Asian Pac J Cancer Prev, 2013. PMID 23534704
2013 / Narrative review
This review examines the pharmacology, efficacy, adverse effects, and dosage of curcuminoids and standardized curcumin extracts. Early human clinical trials suggest potential beneficial effects for conditions such as dyspepsia, peptic ulcer, inflammatory bowel disease, rheumatoid arthritis, osteoarthritis, uveitis, orbital pseudotumor, and pancreatic cancer. Curcumin is generally well-tolerated, with nausea and diarrhea being the most common side effects. The authors note that late-phase clinical trials are still required to confirm most beneficial effects.
Asher GN, Spelman K Altern Ther Health Med, 2013. PMID 23594449
2013 / Narrative review
This review evaluates the gastroprotective and medicinal effects of ginger (Zingiber officinale Roscoe). Animal studies indicate ginger prevents gastric ulcers induced by NSAIDs, reserpine, ethanol, stress, acetic acid, and Helicobacter pylori. Preclinical and clinical studies show anti-emetic effects, though conflicting findings in chemotherapy-induced nausea, vomiting, and motion sickness preclude firm conclusions regarding broad-spectrum efficacy. Further research is needed to firmly establish its utility as a gastroprotective agent in humans.
Haniadka R, Saldanha E, Sunita V, et al. Food Funct, 2013. PMID 23612703
2013 / Narrative review
This review summarizes preclinical and clinical studies evaluating the rhizome of Zingiber officinale (ginger) for preventing nausea and vomiting against various emetogenic stimuli. While ginger has shown antiemetic effects, conflicting reports—particularly regarding motion sickness and chemotherapy-induced nausea and vomiting—prevent firm conclusions. The authors address published study limitations and highlight areas needing further investigation for future clinical application.
Palatty PL, Haniadka R, Valder B, et al. Crit Rev Food Sci Nutr, 2013. PMID 23638927
2013 / Commentary / narrative review of a human trial
This commentary summarizes a human trial assessing the effects of whole grain barley, brown rice, or their combination on fecal microbiota and metabolic/inflammatory markers. Whole grain intake increased gut microbial diversity and induced compositional alterations. The combination of barley and brown rice reduced plasma interleukin-6 (IL-6), which was linked to compositional features of the gut microbiota.
Walter J, Martínez I, Rose DJ Gut Microbes, 2013. PMID 23645316
2013 / Narrative review
This review summarizes environmental and lifestyle risk factors for gastric cancer. Helicobacter pylori is the primary carcinogen, alongside smoking and salt as strong independent risk factors. Red meat and high fat intake are reported to increase gastric cancer risk, whereas fresh fruits, vegetables from the allium family, and micronutrients such as selenium and vitamin C reduce the risk. Obesity contributes to gastric cardia carcinogenesis, while physical activity is considered protective.
Shows an association, not proof of cause and effect.
Lee YY, Derakhshan MH Arch Iran Med, 2013. PMID 23725070
2013 / Narrative review
This review evaluates the health benefits and nutrient density of green and gold kiwifruit cultivars. Kiwifruit as part of a healthy diet may increase HDL cholesterol, decrease triglycerides, platelet aggregation, and elevated blood pressure, while green kiwifruit aids digestion and laxation. Consuming gold kiwifruit with iron-rich meals improves poor iron status, and kiwifruit intake may support immune function and reduce cold or flu-like illness incidence and severity in children and older adults. However, kiwifruit is allergenic, with reported reactions ranging from mild symptoms to severe events.
Stonehouse W, Gammon CS, Beck KL, et al. Can J Physiol Pharmacol, 2013. PMID 23746068
2013 / Narrative review
This review discusses the pharmacology, pharmacokinetics, and clinical evidence regarding curcumin for colonic diseases. Studies suggest curcumin possesses anti-inflammatory, anticancer, and antioxidant properties, functioning as a potential candidate for treating ulcerative colitis, Crohn's disease, and colonic cancer. However, achieving optimum therapeutic levels remains challenging due to curcumin's low solubility and poor bioavailability, prompting development of novel delivery systems to improve absorption.
Sareen R, Jain N, Pandit V Curr Drug Targets, 2013. PMID 23768171
2013 / Narrative review
This review examines non-celiac gluten sensitivity (NCGS) in individuals who lack celiac disease or wheat allergy but seem to benefit from a gluten-free diet. The authors focus on the gastrointestinal manifestations of NCGS, discuss the evidence for the condition, review its putative pathogenesis, and outline areas of controversy and priorities for future research.
Mooney PD, Aziz I, Sanders DS Neurogastroenterol Motil, 2013. PMID 23937528
2013 / Literature review
Authors reviewed Medline, Embase, and Cochrane databases from 1975 to 2012 regarding diet in Crohn's disease (CD) and ulcerative colitis (UC). Enteral nutrition with formula-defined feed is an effective treatment for CD, but approximately 50% of patients relapse within 6 months of returning to a normal diet. Indirect evidence supports lower intakes of animal fat, insoluble fibre, and emulsifiers in CD, and some evidence supports vitamin D supplementation. In UC, high intakes of meat and margarine correlate with increased incidence, and high meat intake correlates with higher relapse likelihood. Overall, there is little interventional evidence to support specific dietary changes.
Shows an association, not proof of cause and effect.
Richman E, Rhodes JM Aliment Pharmacol Ther, 2013. PMID 24102340
2013 / Narrative review
This review summarizes biological issues associated with the synthetic sweetener sucralose. Findings show that sucralose interacts with alimentary chemosensors and, in both human and rodent studies, may alter glucose, insulin, and glucagon-like peptide 1 (GLP-1) levels. Animal studies demonstrate increased intestinal expression of P-gp and two CYP isozymes, altered gut microbial composition, and evidence of gastrointestinal metabolism into unidentified metabolites. Additionally, sucralose and a hydrolysis product were mutagenic at elevated concentrations in several tests, and cooking at high temperatures generated potentially toxic chloropropanols.
Schiffman SS, Rother KI J Toxicol Environ Health B Crit Rev, 2013. PMID 24219506
2013 / Narrative review
This review examines the role of inflammation and oxidative and nitrosative stress as potential mediators of environmental risk factors for depression. The authors identify several factors associated with systemic inflammation that appear to increase the risk of depression, including psychosocial stressors, poor diet, physical inactivity, obesity, smoking, altered gut permeability, atopy, dental caries, sleep disturbances, and vitamin D deficiency. They conclude that because most of these inflammatory sources are plastic, they represent potential targets for preventative and therapeutic interventions.
Shows an association, not proof of cause and effect.
Berk M, Williams LJ, Jacka FN, et al. BMC Med, 2013. PMID 24228900
2013 / Narrative review
This review describes the clinical picture and radiological findings of cobalamin deficiency. Vitamin B12 deficiency causes hematological, gastrointestinal, psychiatric, and neurological disorders, with neuropsychiatric symptoms represented by myelopathy, neuropathy, dementia, and less often optic nerve atrophy potentially preceding hematologic signs. Subacute combined degeneration presents as symmetric dysesthesia, position sense disturbance, and spastic paraparesis or tetraparesis, with MRI most consistently showing symmetrical increased T2 signal intensity in posterior or lateral columns. In healthy elderly subjects, vitamin B12 deficiency has been correlated negatively with cognitive functioning.
Briani C, Dalla Torre C, Citton V, et al. Nutrients, 2013. PMID 24248213
2013 / Review
Ingestion of dietary gluten can trigger allergic, autoimmune, or nonallergic and nonautoimmune responses. Wheat allergy represents an allergic response, celiac disease is an autoimmune condition, and nonceliac gluten sensitivity represents a nonallergic, nonautoimmune condition. This review evaluates diagnostic tools and insights for the differential diagnosis among these conditions, noting that nonceliac gluten sensitivity diagnosis relies on demonstrating gluten-dependency in symptoms after excluding wheat allergy and celiac disease.
Picarelli A, Borghini R, Isonne C, et al. Pol Arch Med Wewn, 2013. PMID 24343168
2013 / Narrative review
This review examines current knowledge on non-celiac gluten sensitivity (NCGS) and potential pathogenic pathways of gluten-related disorders. NCGS is characterized by gastrointestinal or extraintestinal symptoms that respond to gluten withdrawal in the absence of celiac disease or wheat allergy, with significant symptom overlap with irritable bowel syndrome. No discriminative diagnostic markers have yet been identified, and its pathogenesis remains obscure.
Nijeboer P, Bontkes HJ, Mulder CJ, et al. J Gastrointestin Liver Dis, 2013. PMID 24369326
2012 / Narrative review
This review evaluates key laboratory diagnostic aspects of celiac disease (CD) and gluten intolerance. Large-scale epidemiological studies indicate a CD prevalence of 0.3% to 1.2% in the general population, with only 10% to 20% of cases detected via clinical findings. Topics reviewed include test combinations for early and accurate diagnosis, antibodies against transglutaminase-gliadin neoepitopes, non-celiac gluten sensitivity, and cytokine measurements.
Bizzaro N, Tozzoli R, Villalta D, et al. Clin Rev Allergy Immunol, 2012. PMID 21181303
2012 / Narrative review of prospective and retrospective studies
Authors searched PubMed, Medline, and the Cochrane Library to review current evidence on dietary risk factors for inflammatory bowel disease. Prospective studies of European cohorts indicated that a diet high in protein from meat and fish is associated with a higher risk of inflammatory bowel disease. Additionally, intake of the n-6 polyunsaturated fatty acid linoleic acid may confer risk of ulcerative colitis, whereas n-3 polyunsaturated fatty acids may be protective. No effect on ulcerative colitis risk was found for dietary fibres, sugar, macronutrients, total energy, vitamin C, D, E, carotene, or retinol, and no prospective data were found for fruits, vegetables, or food microparticles.
Shows an association, not proof of cause and effect.
Andersen V, Olsen A, Carbonnel F, et al. Dig Liver Dis, 2012. PMID 22055893